Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Dysregulation of DNA Methylation Involves in Progression of Myeloid Leukemia in Down Syndrome

Satoshi Saida, MD PhD, Masahiro Nakamura, MD PhD, Tsutomu Toki, PhD, Yoko Nishinaka-Arai, PhD, Kiminori Terui, MDPhD, Kenichi Yoshida, MD PhD, Seishi Ogawa, MD PhD, Tatsutoshi Nakahata, MD PhD, Toshio Heike, MD PhD, Ken-ichiro Watanabe, MD PhD, Akira Watanabe, PhD, Etsuro Ito, MD PhD

Blood (2015) 126 (23): 89.

https://doi.org/10.1182/blood.V126.23.89.89

Published: 2015

Journal Articles

Outcomes of Stem Cell Transplantation with Fludarabine and Melphalan Conditioning for Children with Acquired Bone Marrow Failure: A Nationwide Retrospective Study

Nao Yoshida, MD PhD, Hiromasa Yabe, MD PhD, Kazuko Kudo, MDPhD, Ryoji Kobayashi, MD PhD, Miharu Yabe, MD PhD, Masami Inoue, MD, Mizuka Miki, MD PhD, Hisashi Sakamaki, MDPhD, Koji Kato, MDPhD, Keisei Kawa, MD PhD, Ritsuro Suzuki, MD PhD, Ken-ichiro Watanabe, MD PhD, Seiji Kojima, MD PhD

Blood (2014) 124 (21): 2559.

https://doi.org/10.1182/blood.V124.21.2559.2559

Published: 2014

Journal Articles

Phase I/II Clinical Trial of Erwinia Asparaginase (Erwinase R ) in Combination with Prednisolone, Vincristine and Pirarubicin in Children and Young Adults with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

Chitose Ogawa, MD, Atsushi Manabe, MD PhD, Hiroaki Goto, MD PhD, Katsuyoshi Koh, MD, Daisuke Tomizawa, MD PhD, Keitaro Fukushima, MD PhD, Ken-ichiro Watanabe, MD PhD, Keizo Horibe, MD, Atsushi Kikuta, MD PhD, Mitsuma Hamada, PhD, Akira Ohara, MD PhD

Blood (2014) 124 (21): 3657.

https://doi.org/10.1182/blood.V124.21.3657.3657

Published: 2014

Journal Articles

Clonal selection in xenografted TAM recapitulates the evolutionary process of myeloid leukemia in Down syndrome

Blood (2013) 121 (21): 4377–4387.

https://doi.org/10.1182/blood-2012-12-474387

Published: 2013

Includes: Supplemental data

Journal Articles

Rabbit antithymocyte globulin and cyclosporine as first-line therapy for children with acquired aplastic anemia

Yoshiyuki Takahashi, Hideki Muramatsu, Naoki Sakata, Nobuyuki Hyakuna, Kazuko Hamamoto, Ryoji Kobayashi, Etsuro Ito, Hiroshi Yagasaki, Akira Ohara, Akira Kikuchi, Akira Morimoto, Hiromasa Yabe, Kazuko Kudo, Ken-ichiro Watanabe, Shouichi Ohga, Seiji Kojima

Blood (2013) 121 (5): 862–863.

https://doi.org/10.1182/blood-2012-11-465633

Published: 2013

Journal Articles

Immunosuppressive Therapy with Antithymocyte Globulin and Cyclosporine for Fulminant Aplastic Anemia.

Hiroshi Yagasaki, MD.PhD, Ken-ichiro Watanabe, Kazuko Kudo, Masahiro Tsuchida, MD, PhD, Hiroyuki Shichino, MD, Akira Morimoto, MD, PhD, Ryoji Kobayashi, Hiromasa Yabe, Akira Kikuchi, Shouichi Ohga, MD, PhD, Etsuro Ito, Akira Ohara, MD, PhD, Tatsutoshi Nakahata, MD, PhD, Seiji Kojima

Blood (2012) 120 (21): 2364.

https://doi.org/10.1182/blood.V120.21.2364.2364

Published: 2012

Journal Articles

Expression of Human Leukocyte Antigen B61 Is Associated with Idiopathic Aplastic Anemia, Hepatitis-Associated Aplastic Anemia and Fulminant Hepatic Failure in Children

Yoshiyuki Takahashi, Akira Ohara, Ryoji Kobayashi, Hiromasa Yabe, Akira Kikuchi, Hiroshi Yagasaki, Akira Morimoto, Ken-ichiro Watanabe, Etsuro Ito, Kazuko Kudo, Akinari Fukuda, Seisuke Sakamoto, Mureo Kasahara, Atsuko Nakazawa, Seiji Kojima

Blood (2012) 120 (21): 3487.

https://doi.org/10.1182/blood.V120.21.3487.3487

Published: 2012

Journal Articles

PD0332991, a CDK4/6 Inhibitor, Has An Anti-Leukemic Activity Against Ph + Leukemia with T315I Mutation in Bcr-Abl; In Vivo Analysis Using Xenograft Mice Model

Satoshi Saida, MD, Itaru Kato, MD, Takeshi Inukai, MD, PhD, Atsushi Nemoto, MD, PhD, Kanji Sugita, MD, PhD, Yasuhiro Maeda, MD, PhD, Akira Niwa, MD, PhD, Ken-ichiro Watanabe, MD, PhD, Tatsutoshi Nakahata, MD, PhD, Toshio Heike, MD, PhD

Blood (2011) 118 (21): 2577.

https://doi.org/10.1182/blood.V118.21.2577.2577

Published: 2011

Journal Articles

Reduced Production of Mature Neutrophils From Induced Pluripotent Stem Cells Derived From a Severe Congenital Neutropenia Patient with HAX1 Gene Deficiency

Tatsuya Morishima, MD, Ken-ichiro Watanabe, MD, PhD, Akira Niwa, MD, PhD, Takayuki Tanaka, MD, Katsutsugu Umeda, MD, PhD, Hidefumi Hiramatsu, MD, PhD, Kousaku Matsubara, MD, PhD, Souichi Adachi, MD, PhD, Tatsutoshi Nakahata, MD, PhD, Toshio Heike, MD, PhD

Blood (2011) 118 (21): 2402.

https://doi.org/10.1182/blood.V118.21.2402.2402

Published: 2011

Journal Articles

Low-Dose Cytosine Arabinoside Therapy for Neonates with Down Syndrome (DS) and Transient Leukemia (TL).

Hideki Muramatsu, MD, PhD, Yasuhide Hayashi, MD, PhD, Machiko Kawamura, MD, PhD, Seiji Kojima, MD, PhD, Miharu Yabe, Keiichi Isoyama, Tomohiko Taki, MD, PhD, Kohichiro Tsuji, MD, PhD, Masahiro Tsuchida, MD, PhD, Atsushi Manabe, Etsuro Ito, MD, PhD, Shotaro Iwamoto, MD, PhD, Hiromi Kato, Aiko Sumie, Takashi Taga, MD, PhD, Keiko Nomura, Daisuke Hasegawa, MD, PhD, Ken-ichiro Watanabe, Akira Kikuchi

Blood (2010) 116 (21): 1074.

https://doi.org/10.1182/blood.V116.21.1074.1074

Published: 2010

Journal Articles

The Bcr-Abl Kinase Inhibitor INNO-406 Induces Autophagy and Different Modes of Cell Death Execution in Bcr-Abl-Positive Leukemias.

Yuri Kamitsuji, MD, Junya Kuroda, PhD, Shinya Kimura, PhD, Ken-ichiro Watanabe, PhD, Eishi Ashihara, PhD, Yoshihiro Yui, MD, Motonobu Watanabe, MD, Hiroshi Matsubara, MD, Yasuhiro Mizushima, MD, Yoshimi Hiraumi, MD, Hideo Tanaka, PhD, Eri Kawata, MD, Taira Maekawa, MD, Tatsutoshi Nakahata, PhD, Souichi Adachi, PhD

Blood (2007) 110 (11): 2951.

https://doi.org/10.1182/blood.V110.11.2951.2951

Published: 2007

Journal Articles

The Significance of BAALC Expression and CEBPa Mutations as New Prognostic Factors in Pediatric Acute Myeloid Leukemia with Normal Karyotype.

Yasuhiro Mizushima, Souichi Adachi, Tomohiko Taki, Akira Shimada, Yasuhide Hayashi, Ichiro Tsukimoto, Masahiro Yui, Yuri Kamitsuji, Yoshimi Hiraumi, Hiroshi Matsubara, Motonobu Watanabe, Ken-ichiro Watanabe, Tatsutoshi Nakahata

Blood (2006) 108 (11): 2279.

https://doi.org/10.1182/blood.V108.11.2279.2279

Published: 2006

Journal Articles

Cell Death Mechanisms Induced by INNO-406, a Novel Tyrosine Kinase Inhibitor for Imatinib-Resistant Ph+ Leukemia.

Yuri Kamitsuji, MD, Souichi Adachi, MD, PhD, Motonobu Watanabe, MD, Hiroshi Matsubara, MD, Yasuhiro Mizushima, MD, Yoshimi Hiraumi, MD, Ken-Ichiro Watanabe, MD, PhD, Hideo Tanaka, MD, PhD, Junya Kuroda, MD, PhD, Eishi Ashihara, MD, PhD, Shinya Kimura, MD, PhD, Taira Maekawa, MD, Tatsutoshi Nakahata, MD, PhD

Blood (2006) 108 (11): 2177.

https://doi.org/10.1182/blood.V108.11.2177.2177

Published: 2006

Journal Articles

Characterization of siRNA-Mediated SBDS-Knockdown Cells: Specific Hypersensitivity to Fas Stimulation.

Ken-ichiro Watanabe, MD, Yigal Dror, MD

Blood (2005) 106 (11): 386.

https://doi.org/10.1182/blood.V106.11.386.386

Published: 2005

Journal Articles

A novel mechanism for imatinib mesylate–induced cell death of BCR-ABL–positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity

Masayuki Okada, Souichi Adachi, Tsuyoshi Imai, Ken-ichiro Watanabe, Shin-ya Toyokuni, Masaki Ueno, Antonis S. Zervos, Guido Kroemer, Tatsutoshi Nakahata

Blood (2004) 103 (6): 2299–2307.

https://doi.org/10.1182/blood-2003-05-1605

Published: 2004

NARROW

Dysregulation of DNA Methylation Involves in Progression of Myeloid Leukemia in Down Syndrome

Outcomes of Stem Cell Transplantation with Fludarabine and Melphalan Conditioning for Children with Acquired Bone Marrow Failure: A Nationwide Retrospective Study

Phase I/II Clinical Trial of Erwinia Asparaginase (Erwinase R ) in Combination with Prednisolone, Vincristine and Pirarubicin in Children and Young Adults with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

Clonal selection in xenografted TAM recapitulates the evolutionary process of myeloid leukemia in Down syndrome

Rabbit antithymocyte globulin and cyclosporine as first-line therapy for children with acquired aplastic anemia

Immunosuppressive Therapy with Antithymocyte Globulin and Cyclosporine for Fulminant Aplastic Anemia.

Expression of Human Leukocyte Antigen B61 Is Associated with Idiopathic Aplastic Anemia, Hepatitis-Associated Aplastic Anemia and Fulminant Hepatic Failure in Children

PD0332991, a CDK4/6 Inhibitor, Has An Anti-Leukemic Activity Against Ph + Leukemia with T315I Mutation in Bcr-Abl; In Vivo Analysis Using Xenograft Mice Model

Reduced Production of Mature Neutrophils From Induced Pluripotent Stem Cells Derived From a Severe Congenital Neutropenia Patient with HAX1 Gene Deficiency

Low-Dose Cytosine Arabinoside Therapy for Neonates with Down Syndrome (DS) and Transient Leukemia (TL).

The Bcr-Abl Kinase Inhibitor INNO-406 Induces Autophagy and Different Modes of Cell Death Execution in Bcr-Abl-Positive Leukemias.

The Significance of BAALC Expression and CEBPa Mutations as New Prognostic Factors in Pediatric Acute Myeloid Leukemia with Normal Karyotype.

Cell Death Mechanisms Induced by INNO-406, a Novel Tyrosine Kinase Inhibitor for Imatinib-Resistant Ph+ Leukemia.

Characterization of siRNA-Mediated SBDS-Knockdown Cells: Specific Hypersensitivity to Fas Stimulation.

A novel mechanism for imatinib mesylate–induced cell death of BCR-ABL–positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only